Company details
About
Alentis is exploiting the functional role of CLDN1 and its associated pathways in disease biology to develop breakthrough therapies for fibrotic diseases and associated cancers. These include liver and kidney disease as well as hepatobiliary cancer.
Number of employees
1 - 10
Main industry
Health Care
Industry tags
Founded in
2019
Headquarters
Basel
Country
Switzerland
Sign up to uncover company details
5 free credit every month
Employee contacts
Name
Job Title
Phone
Reach Decision Makers
at Alentis Therapeutics
